Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016, Article ID 8089217, 7 pages
http://dx.doi.org/10.1155/2016/8089217
Research Article

Diagnostic Value of Fecal Calprotectin (S100 A8/A9) Test in Children with Chronic Abdominal Pain

1Department of Pediatrics, Gastroenterology and Nutrition, Pediatric Institute College of Medicine, Jagiellonian University, Cracow, Poland
2Department of Pediatrics, Pediatric Institute College of Medicine, Jagiellonian University, Cracow, Poland
3Department of Clinical Biochemistry, Pediatric Institute College of Medicine, Jagiellonian University, Cracow, Poland

Received 21 June 2016; Revised 28 September 2016; Accepted 19 October 2016

Academic Editor: Paolo Gionchetti

Copyright © 2016 Stanisław Pieczarkowski et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. K. Chitkara, D. J. Rawat, and N. J. Talley, “The epidemiology of childhood recurrent abdominal pain in western countries: a systematic review,” American Journal of Gastroenterology, vol. 100, no. 8, pp. 1868–1875, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Rasquin-Weber, P. E. Hyman, S. Cucchiara et al., “Childhood functional gastrointestinal disorders,” Gut, vol. 45, supplement 2, pp. II60–II68, 1999. View at Google Scholar · View at Scopus
  3. J. A. Tibble and I. Bjarnason, “Non-invasive investigation of inflammatory bowel disease,” World Journal of Gastroenterology, vol. 7, no. 4, pp. 460–465, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Caccaro, R. Dinc, and G. C. Sturniolo, “Clinical utility of calprotectin and lactoferrin as markers of inflammation in patients with inflammatory bowel disease,” Expert Review of Clinical Immunology, vol. 6, no. 4, pp. 551–558, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. H. N. Iskandar and M. A. Ciorba, “Biomarkers in inflammatory bowel disease: current practices and recent advances,” Translational Research, vol. 159, no. 4, pp. 313–325, 2012. View at Publisher · View at Google Scholar
  6. R. Sidhu, P. Wilson, A. Wright et al., “Faecal lactoferrin—a novel test to differentiate between the irritable and inflamed bowel?” Alimentary Pharmacology and Therapeutics, vol. 31, no. 12, pp. 1365–1370, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Costa, M. G. Mumolo, M. Bellini et al., “Role of faecal calprotectin as non-invasive marker of intestinal inflammation,” Digestive and Liver Disease, vol. 35, no. 9, pp. 642–647, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Carroccio, G. Iacono, M. Cottone et al., “Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children,” Clinical Chemistry, vol. 49, no. 6, pp. 861–867, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. A. G. Røseth, “Determination of faecal calprotectin, a novel marker of organic gastrointestinal disorders,” Digestive and Liver Disease, vol. 35, no. 9, pp. 607–609, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. C. P. Tamboli, F. Richard, and J.-F. Colombel, “Fecal calprotectin in Crohn's disease: new family ties,” Gastroenterology, vol. 124, no. 7, pp. 1972–1974, 2003. View at Google Scholar · View at Scopus
  11. C. B. Summerton, M. G. Longlands, K. Wiener, and D. R. Shreeve, “Faecal calprotectin: a marker of inflammation throughout the intestinal tract,” European Journal of Gastroenterology and Hepatology, vol. 14, no. 8, pp. 841–845, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Aadland and M. K. Fagerhol, “Faecal calprotectin: a marker of inflammation throughout the intestinal tract,” European Journal of Gastroenterology and Hepatology, vol. 14, no. 8, pp. 823–825, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Olafsdottir, L. Aksnes, and A. Berstad, “Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children,” Acta Paediatrica, vol. 91, no. 1, pp. 45–50, 2002. View at Publisher · View at Google Scholar
  14. S. K. Bunn, W. M. Bisset, M. J. C. Main, E. S. Gray, S. Olson, and B. E. Golden, “Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease,” Journal of Pediatric Gastroenterology and Nutrition, vol. 33, no. 1, pp. 14–22, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. U. L. Fagerberg, L. Lööf, R. D. Merzoug, L.-O. Hansson, and Y. Finkel, “Fecal calprotectin levels in healthy children studied with an improved assay,” Journal of Pediatric Gastroenterology and Nutrition, vol. 37, no. 4, pp. 468–472, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. M. K. Fagerhol, T. Andersson, C. F. Naess-Andresen et al., “Calprotectin (the L1 leukocyte proptein),” in Stimulus Response Coupling: The Role of Intracellular Calcium Binding Proteins, V. L. Smith and J. R. Dedman, Eds., pp. 187–210, CRC Press, Boston, Mass, USA, 1990. View at Google Scholar
  17. M. K. Fagerhol, I. Dale, and T. Andersson, “Release and quantitation of a leucocyte derived protein (L1),” Scandinavian Journal of Haematology, vol. 24, no. 5, pp. 393–398, 1980. View at Google Scholar · View at Scopus
  18. A. Voganatsi, A. Panyutich, K. T. Miyasaki, and R. K. Murthy, “Mechanism of extracellular release of human neutrophil calprotectin complex,” Journal of Leukocyte Biology, vol. 70, no. 1, pp. 130–134, 2001. View at Google Scholar · View at Scopus
  19. B. Johne, M. K. Fagerhol, T. Lyberg et al., “Functional and clinical aspects of the myelomonocyte protein calprotectin,” Journal of Clinical Pathology—Molecular Pathology, vol. 50, no. 3, pp. 113–123, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. A. G. Røseth, M. K. Fagerhol, E. Aadland, and H. Schjønsby, “Assessment of the neutrophil dominating protein calprotectin in feces: a methodologic study,” Scandinavian Journal of Gastroenterology, vol. 27, no. 9, pp. 793–798, 1992. View at Publisher · View at Google Scholar · View at Scopus
  21. P. F. Van Rheenen, E. Van de Vijver, and V. Fidler, “Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis,” British Medical Journal, vol. 341, no. 7765, Article ID c3369, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Burri and C. Beglinger, “Faecal calprotectin in the diagnosis of inflammatory bowel disease,” Biochemia Medica, vol. 21, no. 3, pp. 245–253, 2011. View at Google Scholar · View at Scopus
  23. P. Henderson, A. Casey, S. J. Lawrence et al., “The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease,” American Journal of Gastroenterology, vol. 107, no. 6, pp. 941–949, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Diamanti, F. Panetta, M. S. Basso et al., “Diagnostic work-up of inflammatory bowel disease in children: the role of calprotectin assay,” Inflammatory Bowel Diseases, vol. 16, no. 11, pp. 1926–1930, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. M. D. Pfefferkorn, J. H. Boone, J. T. Nguyen, B. E. Juliar, M. A. Davis, and K. K. Parker, “Utility of fecal lactoferrin in identifying crohn disease activity in children,” Journal of Pediatric Gastroenterology and Nutrition, vol. 51, no. 4, pp. 425–428, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Aomatsu, A. Yoden, K. Matsumoto et al., “Fecal calprotectin is a useful marker for disease activity in pediatric patients with inflammatory bowel disease,” Digestive Diseases and Sciences, vol. 56, no. 8, pp. 2372–2377, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Kallel, I. Ayadi, S. Matri et al., “Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: A Prospective Study,” European Journal of Gastroenterology and Hepatology, vol. 22, no. 3, pp. 340–345, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Hesham, E. El Din, A. A. Monis et al., “The diagnostic value of faecal calprotectin in differentiating inflammatory bowel diseases (IBD) from irritable bowel syndrome (IBS),” Report and Opinion, vol. 3, no. 1, pp. 1–8, 2011. View at Google Scholar
  29. J. A. Tibble, G. Sigthorsson, R. Foster, I. Forgacs, and I. Bjarnason, “Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease,” Gastroenterology, vol. 123, no. 2, pp. 450–460, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. M. J. Sydora, B. C. Sydora, and R. N. Fedorak, “Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome,” Journal of Crohn's and Colitis, vol. 6, no. 2, pp. 207–214, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. D. A. Drossman, “The functional gastrointestinal disorders and the Rome III process,” Gastroenterology, vol. 130, no. 5, pp. 1377–1390, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Van Assche, A. Dignass, J. Panes et al., “The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis,” Journal of Crohn's and Colitis, vol. 4, no. 1, pp. 7–27, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. C.-C. Chen, J.-L. Huang, C.-J. Chang, and M.-S. Kong, “Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children,” Journal of Pediatric Gastroenterology and Nutrition, vol. 55, no. 5, pp. 541–547, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Bremner, S. Roked, R. Robinson, I. Phillips, and M. Beattie, “Faecal calprotectin in children with chronic gastrointestinal symptoms,” Acta Paediatrica, vol. 94, no. 12, pp. 1855–1858, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. R. B. Canani, L. Rapacciuolo, M. T. Romano et al., “Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice,” Digestive and Liver Disease, vol. 36, no. 7, pp. 467–470, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Burri, M. Manz, P. Schroeder et al., “Diagnostic yield of endoscopy in patients with abdominal complaints: incremental value of faecal calprotectin on guidelines of appropriateness,” BMC Gastroenterology, vol. 14, no. 1, article 57, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. L.-P. Jelsness-Jørgensen, T. Bernklev, and B. Moum, “Calprotectin is a useful tool in distinguishing coexisting irritable bowel-like symptoms from that of occult inflammation among inflammatory bowel disease patients in remission,” Gastroenterology Research and Practice, vol. 2013, Article ID 620707, 4 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Mindemark and A. Larsson, “Ruling out IBD: estimation of the possible economic effects of pre-endoscopic screening with F-calprotectin,” Clinical Biochemistry, vol. 45, no. 7-8, pp. 552–555, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Fengming and W. Jianbing, “Biomarkers of inflammatory bowel disease,” Disease Markers, vol. 2014, Article ID 710915, 11 pages, 2014. View at Publisher · View at Google Scholar